Sheila R. Weiss

1.1k total citations
24 papers, 615 citations indexed

About

Sheila R. Weiss is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sheila R. Weiss has authored 24 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Physiology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sheila R. Weiss's work include Asthma and respiratory diseases (4 papers), Air Quality and Health Impacts (3 papers) and Estrogen and related hormone effects (3 papers). Sheila R. Weiss is often cited by papers focused on Asthma and respiratory diseases (4 papers), Air Quality and Health Impacts (3 papers) and Estrogen and related hormone effects (3 papers). Sheila R. Weiss collaborates with scholars based in United States, Thailand and Belgium. Sheila R. Weiss's co-authors include Carol J. Blaisdell, Sigal Kaplan, Thomas J. Moore, Ilene H. Zuckerman, Mary E. Bollinger, Elissa R. Levine, D. S. Kimes, Euni Lee, Monica F. Myers and Zhenyi Xue and has published in prestigious journals such as PEDIATRICS, Journal of Clinical Epidemiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Sheila R. Weiss

23 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila R. Weiss United States 14 143 119 99 89 65 24 615
Melisa Litchfield Australia 11 76 0.5× 82 0.7× 142 1.4× 32 0.4× 63 1.0× 20 794
Yvonne M. Coyle United States 14 41 0.3× 90 0.8× 86 0.9× 90 1.0× 12 0.2× 26 581
Elham Jafari Iran 15 43 0.3× 82 0.7× 151 1.5× 34 0.4× 130 2.0× 30 919
Sophie H. Bots Netherlands 12 49 0.3× 59 0.5× 180 1.8× 27 0.3× 84 1.3× 23 770
Lianne Parkin New Zealand 14 127 0.9× 40 0.3× 191 1.9× 8 0.1× 78 1.2× 47 823
Sonia M. Grandi Canada 15 306 2.1× 125 1.1× 241 2.4× 17 0.2× 72 1.1× 63 1.3k
Craig Knott United Kingdom 14 88 0.6× 94 0.8× 194 2.0× 21 0.2× 193 3.0× 33 1.0k
Rasool Salahi Iran 9 44 0.3× 41 0.3× 185 1.9× 28 0.3× 69 1.1× 12 672
Igor Karp Canada 17 157 1.1× 60 0.5× 131 1.3× 10 0.1× 47 0.7× 45 958
Paolo Boffetta France 13 26 0.2× 67 0.6× 136 1.4× 87 1.0× 47 0.7× 19 680

Countries citing papers authored by Sheila R. Weiss

Since Specialization
Citations

This map shows the geographic impact of Sheila R. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila R. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila R. Weiss more than expected).

Fields of papers citing papers by Sheila R. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila R. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila R. Weiss. The network helps show where Sheila R. Weiss may publish in the future.

Co-authorship network of co-authors of Sheila R. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila R. Weiss. A scholar is included among the top collaborators of Sheila R. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila R. Weiss. Sheila R. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Ellen T., et al.. (2022). Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3049–3067. 6 indexed citations
2.
Goehring, Earl, Chuntao Wu, Rhonda L. Bohn, et al.. (2021). Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics. Pharmacoepidemiology and Drug Safety. 30(10). 1353–1359. 4 indexed citations
3.
Gallego, Daniel F., Whitney Neufeld‐Kaiser, Sheila R. Weiss, et al.. (2017). Intrauterine Fetal Growth Restriction and Oligohydramnios of Undetermined Etiology. The Journal of Applied Laboratory Medicine. 1(5). 576–580.
4.
Duong, Vu H., Maria R. Baer, Franklin Hendrick, et al.. (2015). Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response. Leukemia Research. 39(6). 586–591. 6 indexed citations
5.
Davidoff, Amy J., Sheila R. Weiss, Maria R. Baer, et al.. (2013). Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines. Leukemia Research. 37(6). 675–680. 25 indexed citations
6.
Chhabra, Pankdeep, Xing Chen, & Sheila R. Weiss. (2013). Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data. Drug Safety. 36(11). 1117–1123. 13 indexed citations
7.
Hirshon, Jon Mark, Sheila R. Weiss, Robert LoCasale, Elissa R. Levine, & Carol J. Blaisdell. (2006). Looking Beyond Urban/Rural Differences: Emergency Department Utilization by Asthmatic Children. Journal of Asthma. 43(4). 301–306. 10 indexed citations
8.
Lee, Euni, et al.. (2006). National patterns of medication use during pregnancy. Pharmacoepidemiology and Drug Safety. 15(8). 537–545. 74 indexed citations
9.
Blaisdell, Carol J., et al.. (2006). Risk areas for pediatric acute care: asthma differs from upper and lower respiratory illness. Health & Place. 13(2). 404–416. 1 indexed citations
10.
Koro, Carol E., Steven J. Bowlin, & Sheila R. Weiss. (2005). Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication. Pharmacoepidemiology and Drug Safety. 14(10). 697–703. 22 indexed citations
11.
Cluxton, Robert J., Zili Li, Pamela C. Heaton, et al.. (2004). Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program. Pharmacoepidemiology and Drug Safety. 14(1). 1–9. 36 indexed citations
12.
Kimes, D. S., Asad Ullah, Elissa R. Levine, et al.. (2003). Relationships between pediatric asthma and socioeconomic/urban variables in Baltimore, Maryland. Health & Place. 10(2). 141–152. 18 indexed citations
13.
Amr, Sania, Mary E. Bollinger, Monica F. Myers, et al.. (2003). Environmental allergens and asthma in urban elementary schools. Annals of Allergy Asthma & Immunology. 90(1). 34–40. 73 indexed citations
14.
Kimes, D. S., et al.. (2003). Temporal dynamics of emergency department and hospital admissions of pediatric asthmatics. Environmental Research. 94(1). 7–17. 40 indexed citations
15.
Blaisdell, Carol J., Sheila R. Weiss, D. S. Kimes, et al.. (2002). Using Seasonal Variations in Asthma Hospitalizations in Children to Predict Hospitalization Frequency. Journal of Asthma. 39(7). 567–575. 38 indexed citations
16.
Moore, Thomas J., Sheila R. Weiss, Sigal Kaplan, & Carol J. Blaisdell. (2002). Reported Adverse Drug Events in Infants and Children Under 2 Years of Age. PEDIATRICS. 110(5). e53–e53. 109 indexed citations
17.
Lee, Euni, Ilene H. Zuckerman, & Sheila R. Weiss. (2002). Patterns of Pharmacotherapy and Counseling for Osteoporosis Management in Visits to US Ambulatory Care Physicians by Women. Archives of Internal Medicine. 162(20). 2362–2362. 16 indexed citations
18.
Weiss, Sheila R., Ilene H. Zuckerman, Xingyue Huang, & Van Doren Hsu. (2001). Clinical Correlates of Estrogen Replacement Therapy Use and Duration of Use among Medicaid Recipients. Journal of Women s Health & Gender-Based Medicine. 10(8). 811–819. 4 indexed citations
19.
Brambilla, Donald, Sonja M. McKinlay, John B. McKinlay, et al.. (1996). Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels?. Journal of Clinical Epidemiology. 49(3). 345–350. 35 indexed citations
20.
Brown, Nancy J., et al.. (1996). Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiology and Drug Safety. 5(3). 149–154. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melisa Litchfield Breakdown of academic impact, for papers by Yvonne M. Coyle Breakdown of academic impact, for papers by Elham Jafari Breakdown of academic impact, for papers by Sophie H. Bots Breakdown of academic impact, for papers by Lianne Parkin Breakdown of academic impact, for papers by Sonia M. Grandi Breakdown of academic impact, for papers by Craig Knott Breakdown of academic impact, for papers by Rasool Salahi Breakdown of academic impact, for papers by Igor Karp Breakdown of academic impact, for papers by Paolo Boffetta
Rankless by CCL
2026